Patents by Inventor Mélanie Monique Laura WILBAUX

Mélanie Monique Laura WILBAUX has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

DOSING REGIMENS FOR N-((5-FLUORO-2,3-DIHYDROBENZOFURAN-4-YL)METHYL)-8-(2-METHYLPYRIDIN-3-YL)-[1,2,4]TRIAZOLO[4,3-C]PYRIMIDIN-5-AMINE, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, FOR USE IN TREATING PRC2-MEDIATED DISEASES OR DISORDERS

Publication number: 20230293529

Abstract: The invention provided herein provides dosage and dosage regimens for N-((5-fluoro-2,3-dihydrobenzofuran-4-yl)methyl)-8-(2-methylpyridin-3-yl)-[1,2,4]triazolo[4,3-c]pyrimidin-5-amine (Compound (1)), or a pharmaceutically acceptable salt thereof, Compound (1) for the treatment of PRC2-mediated diseases or disorders. In addition, the invention provides using such dosage and dosage regimens in methods for treating PRC2-mediated diseases or disorders.

Type: Application

Filed: May 25, 2021

Publication date: September 21, 2023

Inventors: Yi GU, Sebastien JEAY, Yi JIN, Marc LAISNEY, Christophe MEILLE, Prakash Dahyabhai MISTRY, Jonathan Guy MOGGS, Andreas WEISS, Mélanie Monique Laura WILBAUX

DOSING REGIMENS FOR N-((5-FLUORO-2,3-DIHYDROBENZOFURAN-4-YL)METHYL)-8-(2-METHYLPYRIDIN-3-YL)-[1,2,4]TRIAZOLO[4,3-C]PYRIMIDIN-5-AMINE, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, FOR USE IN TREATING PRC2-MEDIATED DISEASES OR DISORDERS